期刊
PLASTIC AND RECONSTRUCTIVE SURGERY
卷 123, 期 3, 页码 790-793出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PRS.0b013e318199edeb
关键词
-
类别
资金
- Dow Corning Corporation
- 3M
- Plastic Surgery Educational Foundation
- Allergan, Inc.
- Danish Registry for Plastic Surgery of the Breast in Copenhagen, Denmark
Background: In the past, concerns about lymphoma among women with breast implants have been raised by anecdotal observations. A recent report of a case-control study from The Netherlands reported an association of breast implants with anaplastic large T-cell lymphoma, but limitations inherent in the study design and the restriction of the association to saline implants preclude any causal evaluation. Methods: To determine whether lymphoma risk is in fact elevated in women with breast implants, the authors have reviewed the evidence from five long-term follow-up studies comprising over 43,000 women with cosmetic breast implants followed for up to 37 years, which reported results specifically regarding the incidence of non-Hodgkin's lymphoma, among other cancers. Results: Overall, there were 48 observed incident cases of non-Hodgkin's lymphoma compared with 53.9 cases expected, yielding a summary standardized incidence ratio of 0.89 (95 percent confidence interval, 0.67 to 1.18). None of the epidemiologic cohort studies reported a primary lymphoma originating in the breast. Conclusions: To date, there is no credible evidence of an increase of non-Hodgkin's lymphoma regardless of site or specifically originating in the breast among women with cosmetic breast implants. (Plast. Reconstr. Surg. 123: 790, 2009.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据